The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenalidomide added to bendamustine-rituximab for untreated chronic lymphocytic leukemia (CLL): A phase 1 study.
 
Jeremy S. Abramson
Consulting or Advisory Role - Gilead Sciences; Infinity Pharmaceuticals; Pharmacyclics
Research Funding - Celgene (Inst); genentech (Inst); Millennium (Inst); Seagen (Inst)
 
Matthew Steven Davids
Consulting or Advisory Role - Genentech; Gilead Sciences
Research Funding - Pharmacyclics (Inst)
 
Lillian Werner
No Relationships to Disclose
 
David Christopher Fisher
No Relationships to Disclose
 
Philippe Armand
No Relationships to Disclose
 
Philip C. Amrein
No Relationships to Disclose
 
Donna S. Neuberg
No Relationships to Disclose
 
Ephraim P. Hochberg
No Relationships to Disclose
 
Jennifer R. Brown
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Pharmacyclics